Company Filing History:
1 out of 38 
1 out of 5 
1 out of 222 
Years Active: 2018
Title: Kenta Murata: Innovator in Anticancer Therapeutics
Introduction
Kenta Murata, a distinguished inventor based in Toyama, Japan, has made significant strides in the field of cancer treatment. With a patent to his name, Murata's work represents a notable contribution to medical innovations aimed at enhancing patient care and survival.
Latest Patents
Murata holds a patent for an anticancer agent and side-effect-alleviating agent. The invention is designed to potentiate antitumor effects while alleviating side effects associated with traditional cancer treatments. This innovative anticancer agent combines arctigenin, a natural compound, with other anticancer components. The method emphasizes that the combination enhances the inhibition of tumor growth and reduces the proportion of cancer stem cells, ultimately leading to improved survival rates for patients. The anticancer agent may be developed as a combination drug or in a kit format, providing versatility in treatment options.
Career Highlights
Kenta Murata has been associated with reputable institutions, including the University of Toyama and Kracie Pharma Ltd. His tenure at these organizations has allowed him to hone his research skills and focus on critical advancements in cancer therapeutics. Murata’s dedication to his research has positioned him as a key figure in the innovation landscape of medical treatments.
Collaborations
Throughout his career, Murata has collaborated with esteemed colleagues, including Hiroyasu Esumi and Masafumi Ikeda. These professional relationships have contributed to the development of his patented inventions and the broader impact of his work within the scientific community.
Conclusion
Kenta Murata's innovative approach to creating effective anticancer agents exemplifies the importance of research and collaboration in the field of medicine. His contributions have the potential to extend survival rates and improve the quality of life for cancer patients, marking him as a notable inventor in the ongoing battle against cancer.